Clinical Trials Directory

Trials / Completed

CompletedNCT03497000

Effects of OCTA-guided PDT in Acute CSC

Effects of Optical Coherence Tomography Angiography-guided Photodynamic Therapy in Acute Central Serous Chorioretinopathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

OCTA-guided PDT is as safe and effective as ICGA-guided PDT in the treatment of acute central serous chorioretinopathy. Or OCTA-guided PDT is more effective than ICGA-guided PDT in the treatment of acute central serous chorioretinopathy, safe as well.

Conditions

Interventions

TypeNameDescription
PROCEDUREOCTA-guided Photodynamic therapyHalf-dose photodynamic therapy using verteporfin under the guidance of OCTA
PROCEDUREICGA-guided Photodynamic therapyHalf-dose photodynamic therapy using verteporfin under the guidance of ICGA

Timeline

Start date
2017-09-01
Primary completion
2017-12-01
Completion
2018-03-27
First posted
2018-04-12
Last updated
2018-04-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03497000. Inclusion in this directory is not an endorsement.